Application of LC-UV/MS Workflows for GLP-1 Analogs

This technical report presents the application of LC-UV/MS workflows aimed at enhancing the efficiency of impurity profiling for GLP-1 analogs. The study outlines the challenges faced in the production and analysis of GLP-1 receptor agonists, particularly in the context of increasing demand for these compounds as treatments for type 2 diabetes and obesity. It details how LC-UV/MS platforms can alleviate the analytical burden during late-stage method development and early manufacturing phases. The report documents the unique capabilities of these workflows in identifying impurities resulting from chemical and thermal stress conditions. It also describes the benefits of using orthogonal mass information to improve decision-making processes in analytical laboratories, thereby increasing productivity and reducing errors. The findings emphasize the importance of integrating mass detection with traditional UV-based methods to enhance the analytical capabilities in the production of GLP-1 analogs, ensuring compliance with safety and quality standards.